Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its classification as a controlled substance.

(UPDATED) In an underwhelming finale to 2 days of debate and discussion over a long-term mortality signal associated with paclitaxel-based devices for PAD, the Circulatory System Devices panel of the ...

SILVER SPRING, Md. — A U.S. Food and Drug Administration Dermatologic and Ophthalmic Drugs Advisory Committee voted down a proposal to open labeling for anti-inflammatory postoperative eye drops to ...

To promote the establishment of universal standards for prescription medication labels -- and to address the widespread problem of patient misinterpretation of medication instructions -- an advisory ...

One of the collections in the CU Boulder Archives details the story of James Field Willard, who was integral to starting the archives. Marie Adams, of Boulder, points out an article she wants the ...